Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8722 |
High Similarity |
NPD3027 |
Phase 3 |
0.8611 |
High Similarity |
NPD1653 |
Approved |
0.8538 |
High Similarity |
NPD1091 |
Approved |
0.8529 |
High Similarity |
NPD1613 |
Approved |
0.8529 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8296 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8258 |
Intermediate Similarity |
NPD3705 |
Approved |
0.8235 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8042 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8038 |
Intermediate Similarity |
NPD7054 |
Approved |
0.803 |
Intermediate Similarity |
NPD1357 |
Approved |
0.8013 |
Intermediate Similarity |
NPD37 |
Approved |
0.7987 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7987 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7974 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7974 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7974 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7871 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7868 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7868 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7862 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7862 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.784 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7826 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7794 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.777 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7692 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD228 |
Approved |
0.7662 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7634 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7628 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7606 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7606 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7594 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7591 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7562 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7556 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7533 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD6842 |
Approved |
0.75 |
Intermediate Similarity |
NPD6841 |
Approved |
0.75 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7432 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7419 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7394 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7389 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7385 |
Intermediate Similarity |
NPD290 |
Approved |
0.7378 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7347 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7338 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7338 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7324 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7292 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD3686 |
Approved |
0.729 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7278 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7278 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7278 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7266 |
Intermediate Similarity |
NPD291 |
Approved |
0.726 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.726 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7237 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7237 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7211 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7206 |
Intermediate Similarity |
NPD6671 |
Approved |
0.72 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7192 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7181 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7181 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7178 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD5773 |
Approved |
0.717 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7162 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1774 |
Approved |
0.7143 |
Intermediate Similarity |
NPD556 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7143 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7124 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7114 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7113 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7105 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7089 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7051 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7051 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7042 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7042 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7032 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7022 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7013 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.6993 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6986 |
Remote Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD5735 |
Approved |
0.6978 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD5762 |
Approved |
0.6974 |
Remote Similarity |
NPD5763 |
Approved |
0.6957 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6951 |
Remote Similarity |
NPD5494 |
Approved |
0.695 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.695 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.695 |
Remote Similarity |
NPD5846 |
Approved |
0.695 |
Remote Similarity |
NPD5126 |
Approved |
0.6948 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD7526 |
Approved |
0.6943 |
Remote Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD52 |
Approved |
0.6939 |
Remote Similarity |
NPD3180 |
Approved |
0.6939 |
Remote Similarity |
NPD3179 |
Approved |
0.6939 |
Remote Similarity |
NPD7095 |
Approved |
0.6923 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD6799 |
Approved |
0.6919 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6917 |
Remote Similarity |
NPD968 |
Approved |
0.6914 |
Remote Similarity |
NPD2563 |
Approved |
0.6914 |
Remote Similarity |
NPD2560 |
Approved |
0.6914 |
Remote Similarity |
NPD5353 |
Approved |
0.6913 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6908 |
Remote Similarity |
NPD6099 |
Approved |
0.6908 |
Remote Similarity |
NPD6100 |
Approved |
0.6908 |
Remote Similarity |
NPD2161 |
Phase 2 |
0.6901 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6899 |
Remote Similarity |
NPD5403 |
Approved |
0.6899 |
Remote Similarity |
NPD2122 |
Discontinued |
0.6894 |
Remote Similarity |
NPD3384 |
Approved |
0.6894 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6894 |
Remote Similarity |
NPD3383 |
Approved |
0.6894 |
Remote Similarity |
NPD3382 |
Approved |
0.6892 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6889 |
Remote Similarity |
NPD3022 |
Approved |
0.6889 |
Remote Similarity |
NPD3021 |
Approved |
0.6879 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6868 |
Remote Similarity |
NPD7680 |
Approved |
0.6867 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6867 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6867 |
Remote Similarity |
NPD447 |
Suspended |
0.6867 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6863 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6861 |
Remote Similarity |
NPD821 |
Approved |
0.6859 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6857 |
Remote Similarity |
NPD1408 |
Clinical (unspecified phase) |
0.6852 |
Remote Similarity |
NPD7819 |
Suspended |
0.6849 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6846 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6846 |
Remote Similarity |
NPD2674 |
Phase 3 |
0.6839 |
Remote Similarity |
NPD4535 |
Phase 3 |
0.6839 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6839
|
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |